rs374950566

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PS3PM1PP3_StrongPP5_Very_Strong

The NM_001048174.2(MUTYH):​c.800C>T​(p.Pro267Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,614,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000215289: "In vitro functional studies demonstrate DNA binding activity and base excision repair activity are severely defective (Ali M et al. Gastroenterology 2008 Aug; 135(2):499-507; Komine K et al. Hum. Mutat., 2015 Jul;36:704-11)."; SCV000685679: Functional studies have shown that this variant has a deleterious impact on mismatch repair and DNA-binding (PMID:18534194, 26377631).; SCV000821747: Experimental studies have confirmed the disrupting effect of this variant in the protein function (PMID:25820570, PMID:26377631).; SCV000293494: Published functional studies demonstrate a damaging effect: defective DNA binding capability, compromised base excision activity, and near absent glycosylase activity (Ali et al., 2008; Brinkmeyer et al., 2015; Komine et al., 2015); SCV001248081: PS3:Moderate; SCV005622987: Functional studies showed this variant had severely defective DNA binding and defective glycosylase activity (PMIDs: 18534194 (2008), 26377631 (2015)). It was also unable to suppress spontaneous mutations compared to the wild-type (PMID:25820570 (2015)).; SCV000545714: Experimental studies have shown that this missense change affects MUTYH function (PMID:18534194, 25820570, 26377631).; SCV004841020: Functional studies have shown that this variant causes deficient mismatch repair and DNA-binding (PMID:18534194, 26377631).; SCV006073854: Several publications report experimental evidence evaluating an impact on protein function and have found that the variant has severely defective glycosylase activity as well as DNA binding activity (e.g. Ali_2008, Komine_2015, Brinkmeyer_2015). PMID:18534194, 35734982, 26377631, 25820570, 19732775; SCV000592700: an in vitro functional study demonstrated that the p.Pro295Leu variant was severely defective in both glycosylase and DNA binding (Ali 2008).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P267S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

MUTYH
NM_001048174.2 missense

Scores

13
5

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:26

Conservation

PhyloP100: 7.74

Publications

29 publications found
Variant links:
Genes affected
MUTYH (HGNC:7527): (mutY DNA glycosylase) This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017]
MUTYH Gene-Disease associations (from GenCC):
  • familial adenomatous polyposis 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, G2P, Orphanet
  • colorectal cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000215289: "In vitro functional studies demonstrate DNA binding activity and base excision repair activity are severely defective (Ali M et al. Gastroenterology 2008 Aug; 135(2):499-507; Komine K et al. Hum. Mutat., 2015 Jul;36:704-11)."; SCV000685679: Functional studies have shown that this variant has a deleterious impact on mismatch repair and DNA-binding (PMID: 18534194, 26377631).; SCV000821747: Experimental studies have confirmed the disrupting effect of this variant in the protein function (PMID: 25820570, PMID: 26377631).; SCV000293494: Published functional studies demonstrate a damaging effect: defective DNA binding capability, compromised base excision activity, and near absent glycosylase activity (Ali et al., 2008; Brinkmeyer et al., 2015; Komine et al., 2015); SCV001248081: PS3:Moderate; SCV005622987: Functional studies showed this variant had severely defective DNA binding and defective glycosylase activity (PMIDs: 18534194 (2008), 26377631 (2015)). It was also unable to suppress spontaneous mutations compared to the wild-type (PMID: 25820570 (2015)).; SCV000545714: Experimental studies have shown that this missense change affects MUTYH function (PMID: 18534194, 25820570, 26377631).; SCV004841020: Functional studies have shown that this variant causes deficient mismatch repair and DNA-binding (PMID: 18534194, 26377631).; SCV006073854: Several publications report experimental evidence evaluating an impact on protein function and have found that the variant has severely defective glycosylase activity as well as DNA binding activity (e.g. Ali_2008, Komine_2015, Brinkmeyer_2015). PMID: 18534194, 35734982, 26377631, 25820570, 19732775; SCV000592700: an in vitro functional study demonstrated that the p.Pro295Leu variant was severely defective in both glycosylase and DNA binding (Ali 2008).
PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 3 benign, 56 uncertain in NM_001048174.2
PP3
MetaRNN computational evidence supports a deleterious effect, 0.984
PP5
Variant 1-45332215-G-A is Pathogenic according to our data. Variant chr1-45332215-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 185242.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001048174.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUTYH
NM_001128425.2
MANE Plus Clinical
c.884C>Tp.Pro295Leu
missense
Exon 10 of 16NP_001121897.1E5KP25
MUTYH
NM_001048174.2
MANE Select
c.800C>Tp.Pro267Leu
missense
Exon 10 of 16NP_001041639.1Q9UIF7-6
MUTYH
NM_012222.3
c.875C>Tp.Pro292Leu
missense
Exon 10 of 16NP_036354.1Q9UIF7-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUTYH
ENST00000710952.2
MANE Plus Clinical
c.884C>Tp.Pro295Leu
missense
Exon 10 of 16ENSP00000518552.2E5KP25
MUTYH
ENST00000456914.7
TSL:1 MANE Select
c.800C>Tp.Pro267Leu
missense
Exon 10 of 16ENSP00000407590.2Q9UIF7-6
MUTYH
ENST00000372098.7
TSL:1
c.875C>Tp.Pro292Leu
missense
Exon 10 of 16ENSP00000361170.3Q9UIF7-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152234
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000119
AC:
3
AN:
251116
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000752
AC:
11
AN:
1461848
Hom.:
0
Cov.:
36
AF XY:
0.0000110
AC XY:
8
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111982
Other (OTH)
AF:
0.0000662
AC:
4
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152234
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41458
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000127
Hom.:
0
Bravo
AF:
0.00000378
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
10
-
-
Familial adenomatous polyposis 2 (10)
10
-
-
not provided (10)
4
-
-
Hereditary cancer-predisposing syndrome (4)
1
-
-
Breast carcinoma (1)
1
-
-
Carcinoma of colon (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Pathogenic
0.51
D
BayesDel_noAF
Pathogenic
0.60
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.65
D
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
1.0
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.43
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.6
H
PhyloP100
7.7
PrimateAI
Uncertain
0.51
T
PROVEAN
Pathogenic
-9.3
D
REVEL
Pathogenic
0.94
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.84
MVP
0.99
MPC
0.55
ClinPred
1.0
D
GERP RS
5.5
PromoterAI
0.0036
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.81
gMVP
0.93
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374950566; hg19: chr1-45797887; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.